{"url_path":"/sec/codx/10-q/2026/item-6","section_key":"item-6","section_title":"Item 6 Exhibits**","topic":"sec","document":{"doc_type":"10-Q","doc_date":"2026-05-14","source_url":"https://www.sec.gov/Archives/edgar/data/1692415/0001493152-26-023085-index.html","accession_number":"0001493152-26-023085","cik":"0001692415","ticker":"CODX","issuer_name":"Co-Diagnostics, Inc.","edgar_url":"https://www.sec.gov/Archives/edgar/data/1692415/0001493152-26-023085-index.html","primary_entity_key":"0001692415","primary_entity_name":"Co-Diagnostics, Inc."},"word_count":253,"has_tables":true,"body_markdown":"**Item\n6. Exhibits**\n\n \n\n**Exhibit\nIndex**\n\n \n\n(a)\nExhibits\n\n \n\n**Exhibit**\n \n**Number\nDescription**\n\n31.1*\n \n[Certification of Chief Executive Officer pursuant to Section 302 of the Sarbanes-Oxley Act of 2002](ex31-1.htm)\n\n31.2*\n \n[Certification of Chief Financial Officer pursuant to Section 302 of the Sarbanes-Oxley Act of 2002](ex31-2.htm)\n\n32.1*\n \n[Certification of Chief Executive Officer pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002](ex32-1.htm)\n\n32.2*\n \n[Certification of Chief Financial Officer pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002](ex32-2.htm)\n\n101.INS\n \nInline XBRL Instance Document\n\n101.SCH\n \nInline XBRL Taxonomy Extension\nSchema Document\n\n101.CAL\n \nInline XBRL Taxonomy Extension\nCalculation Linkbase Document\n\n101.DEF\n \nInline XBRL Taxonomy Extension\nDefinition Linkbase Document\n\n101.LAB\n \nInline XBRL Taxonomy Extension\nLabel Linkbase Document\n\n101.PRE\n \nInline XBRL Taxonomy Extension\nPresentation Linkbase Document\n\n104\n \nCover Page Interactive\nData File\n\n \n\n*\nFiled herewith.\n\n**Incorporated\nherein by reference to Exhibit 10.1 of Form 8-K, filed September 18, 2025, File No. 001-38148.\n\n***\nIncorporated herein by reference to Exhibit 1.1 of Form 8-K, filed September 18, 2025, File No. 001-38148.\n\n \n\n24\n\n \n\n \n\n**SIGNATURES**\n\n \n\nPursuant\nto the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by\nthe undersigned thereunto duly authorized.\n\n \n\n \n**CO-DIAGNOSTICS,\nINC.**\n\n \n \n \n\nDate: May 14, 2026\nBy:\n*/s/\nDwight H. Egan*\n\n \nName:\nDwight H. Egan\n\n \nTitle:\nChief Executive Officer\nand Principal Executive Officer\n\n \n \n \n\nDate: May 14, 2026\nBy:\n*/s/\nBrian Brown*\n\n \nName:\nBrian Brown\n\n \nTitle:\nChief Financial Officer\nand Principal Financial and Accounting Officer\n\n \n\n25\n\n** **"}